Angioedema
Apr 24, 2008
More...
“Cubist brings a wealth of clinical resources and commercial expertise in the development of a hospital-based therapy, which will serve to maximize the potential of DX-88 in the prevention of blood loss during surgery”
CAMBRIDGE, Mass. & LEXINGTON, Mass.-- --Dyax Corp. and Cubist Pharmaceuticals, Inc. via BioSpace
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Angioedema. Please comment. | Jul 17 | Peter | 2 |
| New to all this (from Apr '06) | Apr '06 | Anita | 1 |
Most Popular
